| 
  • If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • Dokkio Sidebar (from the makers of PBworks) is a Chrome extension that eliminates the need for endless browser tabs. You can search all your online stuff without any extra effort. And Sidebar was #1 on Product Hunt! Check out what people are saying by clicking here.

View
 

Puzhko 2015

Page history last edited by reem.elsherif@mail.mcgill.ca 4 years, 4 months ago

Puzhko, Svetlana (2015). Risk of hepatitis C virus transmission among people who inject prescription opioids: examining the contribution of drug use patterns and contexts. McGill Family Medicine Studies Online, 10: e05. 

 

Download Thesis here

 

Introduction: In developed countries, Hepatitis C Virus (HCV) is mainly transmitted through illicit drug injection. Within the last decade, a new population of People Who Inject Drugs (PWID), namely Prescription Opioids (PO) injectors, has emerged both in Canada and worldwide. However, this new group of PWID has not been sufficiently studied. Characterizing PO injectors, and defining the association between PO injection and the risk for HCV seroconversion may be useful for developing specific HCV prevention and treatment programmes.

 

Objectives: The study objectives were: 1) to examine sociodemographic characteristics, drug use patterns, injecting behaviors, and living contexts associated with PO injection in a cohort of PWID in Montreal, 2) to compare HCV incidence rates between PO injectors and non-PO injectors, 3) to examine the association between PO injection, with or without co-use of other drugs, and HCV seroincidence.

 

Methods: Data collected from PWID, who participated in a prospective cohort study (HEPCO Cohort of Montreal), were examined. Eligibility criteria were age of 18 years old or over, drug injection in the previous 6 months, and current residence in Montreal. Data were procured in 2004-2013 by means of a validated, interviewer-administered questionnaire and blood testing for HCV and HIV antibody. Baseline data were assessed in a cross-sectional analysis by Chi-square and Student’s t tests. Logistic regression modeling was applied to identify the correlates of PO injection. HCV negative at baseline PWID were included in the longitudinal analysis. Kaplan-Meier survival and time-varying Cox regression analyses were conducted to calculate the relative rates of HCV seroincidence and examine the association between PO injection and time-to-HCV seroconversion.

 

Results: Cross-sectional analysis. Of 1243 PWID who participated between 2004 and 2011 (83.8% males; mean age: 38.2 years), 380 (30.6%) reported PO injection in the past month. In a multivariate regression analysis, characteristics and behaviors independently associated with PO injection were age (adjusted odds ratio (aOR) by 5-year increment: 0.79; 95% confidence interval [95%CI]: 0.7,0.9), co-use of heroin injection (aOR:3.03, [95%CI: 2.2,4.2]) or non-injection amphetamines (aOR: 1.84; [95%CI: 1.2,2.9]) or non-injection tranquilizers (aOR:2.38, [95%CI: 1.8,3.2]), unstable housing conditions (aOR: 1.78, [95% CI: 1.3,2.4]), injecting in a public place (aOR:2.03, [95%CI: 1.5,2.8]), and HCV seropositivity (aOR: 1.56, [95%CI:1.1,2.2]). Longitudinal analysis. Of 356 participants (81.5% males; mean age: 34.7 years) who were HCV-negative at baseline and were followed up between 2004 and 2013, 123 (34.6%) reported PO injection, and 115 (32%) seroconverted to HCV. Co-use dyads associated with HCV were: PO injection with cocaine injection (crude hazard ratio (cHR): 10.86, [95%CI: 5.8,20.3] vs. use of neither drug), PO injection with crack/cocaine smoking (cHR:4.08, [95%CI: 2.5,6.7]), and PO injection with non-injection tranquilizers (cHR: 4.09, [95%CI: 2.5,6.6]). In a multivariate analysis, PO injection was independently associated with HCV infection. PWID who co-used all three drugs with PO injection had the highest risk of HCV acquisition.

 

Interpretation: Comprehensive harm reduction and HCV prevention strategies for PO injectors in Montreal should address young PWID. In addition, addressing co-use of PO injection with cocaine injection, crack/cocaine smoking, or non-injection use of tranquilizers may also be beneficial. PO injectors who co-use all three drugs should be identified as high priority targets for interventions.

 

 

Comments (0)

You don't have permission to comment on this page.